Table 1

All QTL located in this study

Chr1

Trait2

cM3

F4

a5

d5

Var%6


2

IgG1_week_10

38

5.60

-0.21**

0.26**

5.71

3

IgG2_week_2

58

5.93

0.66**

0.40

6.03

4

IgG1_week_1

31

5.35

-0.63**

0.34

5.46

4

IgG1_week_8

20

5.17

0.12

0.17**

1.18

4

IgG1_week_10

27

4.92

0.23

-0.47*

5.05

4

IgG1_AUC

28

6.37*

0.11

-0.43*

6.64

4

SI_FMDV_Week_0

67

4.79

0.00

-0.14**

4.92

5

SI_CA_Week_0

68

8.10*

-0.13*

0.24**

8.05

5

SI_CA_Week_0

100

5.76

0.22**

-0.14

6.11

5

SI_CA_Week_10

76

5.26

-0.05

0.23**

5.38

5

SI_CA_10 ug_AUC

69

5.89

-0.06

0.17**

6.04

6

SI_CA_Week_0

30

8.69**

0.26***

0.08

8.59

6

SI_FMDV_Week_8

59

6.49

0.14**

-0.08

6.56

6

SI_FMDV_Week_8

133

7.35*

0.04

-0.20***

7.51

6

SI_FMDV_Week_10

3

6.61

0.12**

-0.15*

6.67

6

SI_FMDV_AUC

2

7.91*

0.10***

-0.07

7.96

6

SI_FMDV_AUC

133

6.21

0.03

-0.13**

6.56

7

IgG2_week_8

0

6.24

-0.85***

0.13

6.58

7

SI_CA_Week_10

0

4.89

0.05

0.28**

5.02

7

SI_FMDV_Week_4

54

5.45

-0.11**

-0.09

5.62

9

IgG1_week_0

40

5.29

-0.2948*

0.35

5.41

9

SI_FMDV_Week_10

63

4.92

0.05

-0.23**

5.05

11

IgG1_week_0

0

5.26

0.25

-0.61*

5.38

12

IgG2_week_8

17

5.44

-0.03

1.24***

5.56

13

IgG1_week_1

0

5.08

0.04

-0.54**

5.20

14

IgG2_week_0

2

4.85

0.12

-0.28**

4.98

15

IgG2_week_8

13

5.16

-0.08

1.03**

5.28

15

IgG2_AUC

27

5.39

-0.08

0.67**

5.51

16

IgG2_week_2

76

6.51

-0.71***

-0.16

6.58

16

SI_FMDV_AUC

64

4.42

-0.06*

-0.07*

4.61

18

SI_CA_Week_10

22

7.02*

-0.20***

0.10

7.06

18

IgG2_week_1

57

5.23

-0.10

0.34**

5.40

19

IgG2_week_2

28

4.93

-0.50*

-0.62*

5.06

19

IgG2_week_4

34

5.64

-0.73***

-0.32

5.75

19

IgG2_week_8

50

5.28

-0.81**

-0.25

5.63

19

SI_CA_Week_8

32

8.57*

0.25***

-0.07

8.48

19

SI_CA_Week_10

32

4.54

0.15*

-0.13

4.67

19

SI_CA_10 ug_AUC

28

4.42

0.13**

-0.01

4.61

20

IgG1_week_2

28

4.74

-0.03

0.48**

4.87

20

IgG1_week_4

36

7.86*

0.20**

0.35**

7.83

20

IgG1_week_8

9

6.49*

0.19

0.64**

6.56

20

IgG1_week_10

23

5.37

0.09

0.38**

5.48

20

IgG1_AUC

20

10.07***

0.12

0.39***

9.82

20

IgG2_week_4

32

7.48

0.52**

0.65*

7.48

20

IgG2_week_8

25

8.46

0.76**

0.87*

8.38

20

IgG2_week_10

31

6.23

0.33

0.82**

6.31

20

IgG2_AUC

31

8.5*

0.40**

0.67**

8.41

20

SI_FMDV_Week_0

61

7.95*

0.05

-0.18***

7.92

21

IgG1_week_2

69

4.96

-0.22*

0.38*

5.09

21

SI_CA_10 ug_AUC

84

4.10

-0.14**

-0.01

4.28

23

IgG1_week_0

78

5.11

-0.19

-0.54**

5.24

23

IgG1_week_1

65

5.83

-0.13

-0.87***

5.92

23

IgG1_week_2

39

4.16

0.37

-0.53

4.31

23

IgG1_week_10

18

5.25

0.37**

0.03

5.37

23

IgG1_AUC

18

5.34

0.29**

0.06

5.46

23

IgG2_week_4

0

5.45

0.63**

-0.18

5.57

23

IgG2_week_8

5

5.85

0.88***

-0.18

5.94

23

IgG2_week_10

33

4.08

1.02**

0.77

4.23

23

IgG2_AUC

6

6.61*

0.66***

-0.18

6.67

24

IgG1_week_8

35

7.83**

0.58***

0.32

7.80

24

IgG1_week_10

33

4.18

0.27**

0.06

4.32

24

IgG1_AUC

33

6.23

0.25***

0.12

6.31

24

IgG2_week_10

21

5.09

0.69**

0.61

5.32

24

SI_CA_Week_4

34

5.46

-0.05

0.28**

5.63

25

IgG1_week_0

0

4.48

0.34*

0.28

4.62

25

IgG1_week_1

0

4.88

0.29*

0.35*

5.01

25

IgG1_week_2

33

4.42

0.05

-0.35**

4.66

25

IgG2_week_1

15

4.48

0.18**

-0.11

4.62

25

IgG2_week_2

34

4.65

-0.14

-0.73**

4.78

25

IgG2_week_4

34

4.85

-0.14

-0.70**

4.98

25

IgG2_AUC

34

5.28

-0.04

-0.62**

5.40

25

SI_CA_Week_10

17

5.79

-0.11*

0.19**

5.89

26

IgG1_week_1

21

4.90

-0.30*

0.35

5.25

27

IgG2_week_4

7

4.61

-0.57**

-0.33

4.75

29

SI_CA_Week_0

0

5.34

0.15**

-0.11

5.69

29

SI_FMDV_Week_8

7

4.90

-0.10*

0.12

5.03

29

SI_FMDV_Week_10

0

4.38

-0.11**

0.08

4.61


1. Chr: the chromosome number of the QTL. Underlined if 2 QTL model.

2. Trait: each trait is shown as follows: trait type (IgG1; IgG2; SI_FMDV = T cell proliferation to the FMDV peptide; SI_CA = T cell proliferation to Concanavalin A), followed by week post immunisation.

3. cM: the position the QTL is on the chromosome, in centiMorgans.

4. F: the F-statistic for each QTL. Significance level: all are at least 5% chromosome wide, * = p < 1% chromosome wide, **= p < 5% genome wide and ***= p < 1% genome wide.

5. "a" and "d" are the additive and dominance effect, respectively, of each QTL, * = p < 5%, **= p < 1% and ***= p < 0.01%.

6. Var%: the phenotypic variance explained by the QTL.

Clusters of related traits have been boxed, 6 in total

Leach et al. BMC Genetics 2010 11:107   doi:10.1186/1471-2156-11-107

Open Data